Directive of the European Parliament and of the Council

To patent or not to patent: the European Union's new biotech directive.

IV. PATENTABILITY OF BIOTECHNOLOGICAL INVENTIONS IN EUROPE............................................................................ 583 A. The European Patent Convention............................. 583 B. Directive 98/44/EC of the European Parliament and the Council of the European Union on the Legal Protection of Biotechnological Inventions ...... 589 1. Procedure for Adoption of a Directi...

The New EU Directive Concerning the Legal Protection of Databases

On September 14, 1995, the Commission accepted the Common Position and transmitted its opinion to the European Parliament. The European Parliament dealt with the Common Position in a second reading which began on September 21, 1995. On December 14, 1995, it adopted a decision approving the Common Position subject to eight minor drafting changes. The Commission’s opinion on the European Parliame...

Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions.

The Proposed Ban on Certain Nanomaterials for Electrical and Electronic Equipment in Europe and Its Global Security Implications: A Search for an Alternative Regulatory Approach

On 15 June 2010, a Member of the European Parliament, Jill Evans, introduced the Report on the Proposal for a Directive of the European Parliament and of the Council on the Restriction of the Use of Certain Hazardous Substances in electrical and Electronic Equipment (Recast), to the Committee on the Environment, Public Health and Food Safety of the European Parliament. This Report was seen by m...

European medical device regulation: a new era?

By the spring of 2005, the European Commission hopes to present the first draft of the revisions to the Medical Device Directive to the European Council and Parliament. However, these revisions represent only part of the changing European regulatory scenario. This article discusses a tangible shift in European medical device regulatory policy and some actions that companies can take to understa...